Silencing fibronectin extra domain a enhances radiosensitivity in nasopharyngeal carcinomas involving an FAK/Akt/JNK pathway

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 4, 2012, Pages

  Ou, Juanjuan ^a   Pan, Feng ^a   Geng, Peiliang ^a   Wei, Xing ^a   Xie, Ganfeng ^a   Deng, Jia ^a   Pang, Xueli ^a   Liang, Houjie ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

EDA; Head and neck carcinoma; Radioresistance

Indexed keywords

ANGIOGENESIS; ANTIAPOPTOTIC; APOPTOTIC GENES; BLOOD SAMPLES; CANCER CELLS; CASPASE-3; CASPASES; EDA; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPRESSION LEVELS; HEAD-AND NECK-CARCINOMA; IMMUNOHISTOCHEMISTRY; IN-VITRO; IN-VIVO; LYMPH NODE METASTASIS; LYMPHANGIOGENESIS; MALIGNANT TUMORS; MOLECULAR LEVELS; NASOPHARYNGEAL CARCINOMA; RADIORESISTANCE; TUMOR TISSUES; WESTERN BLOTS;

BIOLOGICAL MATERIALS; BLOOD; CELL DEATH; ENZYME INHIBITION; FLOW CYTOMETRY; HISTOLOGY; PATHOLOGY; PHOSPHORYLATION; TUMORS;

GENE EXPRESSION;

CASPASE 3; CASPASE 9; FIBRONECTIN; FIBRONECTIN EXTRA DOMAIN A; FOCAL ADHESION KINASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BCL 2; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CANCER CELL; CANCER STAGING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE METASTASIS; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; RADIOSENSITIVITY; WESTERN BLOTTING;

ANIMALS; CASPASE 3; CASPASE 9; CELL LINE, TUMOR; FEMALE; FIBRONECTINS; FOCAL ADHESION KINASE 1; HUMANS; LENTIVIRUS; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED BALB C; MICE, NUDE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM PROTEINS; POLY(ADP-RIBOSE) POLYMERASES; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; RADIATION TOLERANCE; TRANSPLANTATION, HETEROLOGOUS; TUMOR STEM CELL ASSAY;

EID: 84857919546     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.09.040     Document Type: Article

References (20)

1. D. Raben, C. Bianco, and L. Milas Targeted therapies and radiation for the treatment of head and neck cancer: Are we making progress? Semin Radiat Oncol 14 2004 139 152
2. J. Bernier A multidisciplinary approach to squamous cell carcinomas of the head and neck: An update Curr Opin Oncol 20 2008 249 255
3. M. Jamal, B.H. Rath, and E.S. Williams Microenvironmental regulation of glioblastoma radioresponse Clin Cancer Res 16 2010 6049 6059
4. P.M. Harari, D.L. Wheeler, and J.R. Grandis Molecular target approaches in head and neck cancer: Epidermal growth factor receptor and beyond Semin Radiat Oncol 19 2009 63 68
5. C. ffrench-Constant Alternative splicing of fibronectin - many different proteins but few different functions Exp Cell Res 221 1995 261 271
6. J.J. Ou, F. Wu, and H.J. Liang Colorectal tumor derived fibronectin alternatively spliced EDA domain exerts lymphangiogenic effect on human lymphatic endothelial cells Cancer Biol Ther 9 2010 186 191
7. Chen Yuying, Wang Zhanxiang, and Chang Pingan The effect of focal adhesion kinase gene silencing on 5-fluorouracil chemosensitivity involves an Akt/NF-kB signaling pathway in colorectal carcinomas Int J Cancer 127 2010 195 206
8. Ou Juanjuan, Li Jianjun, and pan Feng Endostatin suppresses colorectal tumor-induced lymphangiogenesis by inhibiting expression of fibronectin extra domain A and integrin α9 J Cell Biochem 112 2011 2106 2114
9. J.N. Rybak, C. Roesli, and M. Kaspar The extra-domain A of fibronectin is a vascular marker of solid tumors and metastases Cancer Res 67 2007 10948 10957
10. S. Narayan, J. Lehmann, and M.A. Coleman Prospective evaluation to establish a dose response for clinical oral mucositis in patients undergoing head-and-neck conformal radiotherapy Int J Radiat Oncol Biol Phys 72 2008 756 762
11. J.R. Williams, Y. Zhang, and H. Zhou Sequentially-induced responses define tumour cell radiosensitivity Int J Radiat Biol Phys 87 2011 628 643
12. A. Yaromina, M. Krause, and H. Thames Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumor control after fractionated irradiation Radiother Oncol 3 2007 304 310
13. S.H. Park, H.N. Cho, and S.J. Lee Hsp25-induced radioresistance is associated with reduction of death by apoptosis: Involvement of Bcl2 and the cell cycle Radiat Res 154 2000 421 428
14. Y.J. Jin, I. Park, and I.K. Hong Fibronectin and vitronectin induce AP-1-mediated matrix metalloproteinase-9 expression through integrin α(5)β(1)/α (v)β(3)-dependent Akt, ERK and JNK signaling pathways in human umbilical vein endothelial cells Cell Signal 23 2011 125 134
15. S.F. Zerp, R. Stoter, and G. Kuipers AT-101, a small molecule inhibitor of anti-apoptotic Bcl-2 family members, activates the SAPK/JNK pathway and enhances radiation-induced apoptosis Radiat Oncol 4 2009 47
16. M.A. Christophorou, I. Ringshausen, and A.J. Finch The pathological response to DNA damage does not contribute to p53- mediated tumour suppression Nature 443 2006 214 217
17. L.W. Ellisen PARP inhibitors in cancer therapy: Promise, progress, and puzzles Cancer Cell 19 2011 165 167
18. S. Lu, C. Ren, and Y. Liu PI3K-Akt signaling is involved in the regulation of p21(WAF/CIP) expression and androgen-independent growth in prostate cancer cells Int J Oncol 28 2006 245 251
19. P. Xie, V.K. Kondeti, and L. Sun Role of extracellular matrix renal tubulo-interstitial nephritis antigen in cell survival utilizing integrin {α}V{β}3/FAK/PI3kinase/AKT signaling pathway J Biol Chem 286 2011 34131 34146
20. S. Zhang, Z.N. Lin, and C.F. Yang Suppressed NF-kappaB and sustained JNK activation contribute to the sensitization effect of parthenolide to TNF-alpha-induced apoptosis in human cancer cells Carcinogenesis 25 2004 2191 2199